MIRO 0.00 Miromatrix Medical Inc.
| Range: | 0.906-4.35 | Vol Avg: | 163022 | Last Div: | 0 | Changes: | 0.02 |
| Beta: | 0.02 | Cap: | 0.09B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Thu Jun 24 2021 | Empoloyees: | 76 | ||
| CUSIP: | 60471P108 | CIK: | 0001527096 | ISIN: | US60471P1084 | Country: | US |
| CEO: | Dr. Jeffrey James Ross Ph.D. | Website: | https://www.miromatrix.com | ||||
Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells. The company has collaborations with The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company was formerly known as TayTech, Inc. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow